These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1699023)

  • 1. [Assessment of anti-arrhythmic activity of palpitin and cardio-hemodynamic effects of its administration].
    Kurakina TI; Gorshkov VA; Nesvetov VN
    Kardiologiia; 1990 Jun; 30(6):73-6. PubMed ID: 1699023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effectiveness of palpitin in treating heart rhythm disorders in ischemic heart disease patients].
    Kurakina TI; Gorshkov VA; Sherashov VS; Solov'eva FV
    Kardiologiia; 1987 May; 27(5):39-41. PubMed ID: 3116314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Palpitin--an anti-arrhythmic drug in ischemic heart disease].
    Kuch J; Mamcarz A; Król J; Sawicki J; Braksator W
    Wiad Lek; 1990 Jan 1-15; 43(1-2):23-7. PubMed ID: 2114703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the treatment of cardiac arrhythmias with Palpitin.
    Oźarek-Medyńska T; Krynicki M; Polubiec A
    Ther Hung; 1990; 38(1):26-9. PubMed ID: 2111940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of ectopic ventricular activity with palpitin (disopyramide)].
    Penkov N; Mitkova M; Kaponov Kh; Karastatev D
    Vutr Boles; 1987; 26(2):54-7. PubMed ID: 2440188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders].
    Smetnev AS; Ponomarenko EL; Koltunova MI; Shugushev KhKh
    Kardiologiia; 1987 May; 27(5):24-6. PubMed ID: 2443743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability].
    Tatarchenko IP; Pozdniakova NV; Shevyrev VA; Morozova OI
    Kardiologiia; 2003; 43(2):65-8. PubMed ID: 12891276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.
    Arif M; Laidlaw JC; Oshrain C; Willis PW; Nissen CH; McDermott DJ; Smith WS; Karim A; Wilson RR
    Angiology; 1983 Jun; 34(6):393-400. PubMed ID: 6408949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
    Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
    G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the anti-arrhythmic effect of Palpitin (disopyramide).
    Rohla M; Balázsi I
    Ther Hung; 1987; 35(4):196-9. PubMed ID: 3447303
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].
    Fauchier JP; Babuty D; Rouesnel P; Cosnay P; Estepo J
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):553-60. PubMed ID: 1712193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacodynamics and pharmacokinetics of disopyramide phosphate].
    Ol'binskaia LI; Tiukavkina NA; Kuz'mina MM; Beloborodov VL; Klimov AV
    Farmakol Toksikol; 1985; 48(4):73-8. PubMed ID: 3930285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Breithardt G; Haerten K; Seipel L
    Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Echocardiographic indices of cardiac function and systemic hemodynamics in patients with cardiac fibrillation paroxysms and their dynamics as affected by disopyramide phosphate].
    Komarov FI; Ol'binskaia LI; Kuz'mina MM
    Kardiologiia; 1985 Jul; 25(7):71-4. PubMed ID: 3932741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-arrhythmia and hemodynamic effects of allapinin during a course therapy in patients with circulatory failure].
    Khodzhakuliev BG; Naumov VG; Blinov SI; Grigor'iants RA
    Kardiologiia; 1992 Apr; 32(4):41-4. PubMed ID: 1405233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.